| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
|
| L | SIP | IP | | | Ribomustin 25 mg | Durchstechflasche(n) | 58.04 | 79.20 | 10 % | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma
Services GmbH | A / SL / SO | FB | | G |  |
| L | SIP | IP | | | Ribomustin 25 mg | 5 Durchstechflasche(n) | 241.17 | 277.35 | 10 % | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma
Services GmbH | A / SL / SO | FB | | G | |
| L | SIP | IP | | | Ribomustin 100 mg | Durchstechflasche(n) | 187.85 | 219.65 | 10 % | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 100 mg | CPS Cito Pharma
Services GmbH | A / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Arcoxia 30 mg ‐ I | 28 Tablet(s) | 15.38 | 33.05 | 10 % | | Coated tablets: Etoricoxibum 30 mg | Organon GmbH | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Arcoxia 60 mg | 7 Tablet(s) | 6.11 | 15.85 | 10 % | | Coated tablets: Etoricoxibum 60 mg | Organon GmbH | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Arcoxia 60 mg | 28 Tablet(s) | 24.42 | 42.85 | 10 % | | Coated tablets: Etoricoxibum 60 mg | Organon GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Fluvastatin Sandoz Retard | 28 Tablet(s) | 14.71 | 32.40 | 10 % | | Delayed release tablets: Fluvastatinum 80 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Fluvastatin Sandoz Retard | 98 Tablet(s) | 51.40 | 72.30 | 10 % | | Delayed release tablets: Fluvastatinum 80 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | NovoSeven 1 mg | Set(s) | 845.41 | 908.45 | 10 % | | Injection preparation, stable at room temperature: Eptacogum Alfa 1 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| L | | IP | CI | | NovoSeven 2 mg | Set(s) | 1690.88 | 1775.90 | 10 % | | Injection preparation, stable at room temperature: Eptacogum Alfa 2 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| L | | IP | CI | | NovoSeven 5 mg | Set(s) | 4224.20 | 4375.05 | 10 % | | Injection preparation, stable at room temperature: Eptacogum Alfa 5 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| | | IP | CI | | Azarga | 5 ml | 13.15 | 30.70 | 10 % | | Augentropfensuspension: 2 Active Agents | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | IP | CI | | Azarga | 3 x 5 ml | 37.49 | 57.20 | 10 % | | Augentropfensuspension: 2 Active Agents | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | IP | CI | Ph | Kaloba | 20 ml | 4.86 | 9.00 | 10 % | | Tropfen zum Einnehmen: Pelargonii Radicis Extractum Ethanolicum Fluidum (Pelargonium Sidoides dc., Radix) 820.88 mg/ml | Schwabe Pharma AG | D / SL | FB | | G | |
| | | IP | CI | Ph | Kaloba | 50 ml | 9.31 | 17.20 | 10 % | | Tropfen zum Einnehmen: Pelargonii Radicis Extractum Ethanolicum Fluidum (Pelargonium Sidoides dc., Radix) 820.88 mg/ml | Schwabe Pharma AG | D / SL | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 100 ml | 10.80 | 28.15 | 10 % | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | ● A+ / SL | FB | | G | |
| | | IP | | | OLIMEL 3,3 % mit
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 4,4 % mit
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 5,7 % mit
Elektrolyte | 6 x 1000 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 5,7 % mit
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 7,6 % mit
Elektrolyte | 6 x 1000 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 7,6 % mit
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 7,6 % mit
Elektrolyte | 10 x 650 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 5,7 % mit
Elektrolyte | 4 x 2000 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 7,6 % mit
Elektrolyte | 4 x 2000 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 2 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | PeriOLIMEL 2,5 % mit
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 3 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | PeriOLIMEL 2,5 % mit
Elektrolyte | 4 x 2000 ml | PR | PR | k.A. | | Infusion emulsion: 21 Active Agents
Infusion emulsion: 3 Active Agents
Infusion emulsion: 3 Active Agents | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 4,4 % ohne
Elektrolyte | 6 x 1000 ml | PR | PR | k.A. | | Infusion solution: 17 Active Agents
Infusion solution: 2 Active Agents
Infusion solution: Glucosum | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 5,7 % ohne
Elektrolyte | 6 x 1000 ml | PR | PR | k.A. | | Infusion solution: 17 Active Agents
Infusion solution: 2 Active Agents
Infusion solution: Glucosum | Baxter AG | B | FB | | G | |
| | | IP | | | OLIMEL 5,7 % ohne
Elektrolyte | 4 x 1500 ml | PR | PR | k.A. | | Infusion solution: 17 Active Agents
Infusion solution: 2 Active Agents
Infusion solution: Glucosum | Baxter AG | B | FB | | G | |
| | | IP | CI | | NovoSeven 8 mg | Set(s) | PR | PR | k.A. | | Injection preparation, stable at room temperature: Eptacogum Alfa 8 mg | Novo Nordisk Pharma AG | B | FB | | G | |
| | SIP | IP | | | Ribomustin 25 mg | 10 Durchstechflasche(n) | PR | PR | k.A. | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma
Services GmbH | A | FB | | G | |
| | SIP | IP | | | Ribomustin 25 mg | 20 Durchstechflasche(n) | PR | PR | k.A. | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma
Services GmbH | A | FB | | G | |
| | SIP | IP | | | Ribomustin 100 mg | 5 Durchstechflasche(n) | PR | PR | k.A. | | Lyophilisate for infusion solution: Bendamustini Hydrochloridum 100 mg | CPS Cito Pharma
Services GmbH | A | FB | | G | |
| | | IP | CI | Ph | Kaloba | 100 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Pelargonii Radicis Extractum Ethanolicum Fluidum (Pelargonium Sidoides dc., Radix) 820.88 mg/ml | Schwabe Pharma AG | D | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 500 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 1000 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | | CI | H | Camilia | 10 x 1 ml | PR | PR | k.A. | | | Boiron SA | D | FB | | G | |
| | | | CI | H | Camilia | 30 x 1 ml | PR | PR | k.A. | | | Boiron SA | D | FB | | G | |
